Historical control withdrawal to monotherapy

Epilepsy Research

Volumn 68, Issue 1, 2006, Pages 74-77

  French, Jacqueline ^a  

^a HUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PLACEBO; TIAGABINE; TOPIRAMATE;

CLINICAL TRIAL; CONFERENCE PAPER; EPILEPSY; HUMAN; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT DISEASE; SEIZURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ANTICONVULSANTS; CONTROLLED CLINICAL TRIALS; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS;

EID: 30144445554     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.09.027     Document Type: Conference Paper

References (3)

1. F.G. Gilliam, F. Veloso, and M.A. Bomhof A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy Neurology 28 2003 196 202
2. J.H. Karlawish, and J. French The ethical and scientific shortcomings of current monotherapy epilepsy trials in newly diagnosed patients Epilepsy Behav. 2 2001 193 200
3. S. Wang, J.A. French, G. Pledger, and N. Temkin Meta-analysis of withdrawal to monotherapy studies: basis for historical control Epilepsia 43 Suppl. 7 2002 189 (Abstract)